pharmaceutical technology Articles
-
Valuing technology along a timeline of technological maturity
The issue of assessing technology for business application remains a foremost concern for managers in industry. Many managers know that there is something unsatisfactory about the standard use of Discounted Cash Flow (DCF) techniques, particularly when there is high uncertainty and a need for strategic flexibility. However, whatever the lack of hard data, it is also unsettling to rely on pure ...
-
University of Pavia, Lab. Pharmaceutical Technology and Law (PT&L) Italy - Case Study
“The BUCHI Encapsulator B-395 Pro is the instrument of choice on the market for the sterile encapsulation of cells into polymeric beads and capsules, and is integretable into a GMP process.” Customer name Prof. Bice Conti Company / Institution Université de Pavia, Lab. Pharmaceutical Technology and Law (PT&L), Dept. Drug Sciences, Italie Product lines Spray Drying and ...
By BUCHI
-
Adaptive strategies in the Indian pharmaceutical industry
Trade liberalisation and proposed changes in the IPR has ushered in new dynamics in the Indian Pharmaceutical industry. Referring to theoretical debate on industrial organisational policies, the pharmaceutical industry is moving towards consolidation and augmentation, thus towards a "new industrial order". The pharmaceutical industry's adaptation to change, as shown in this article, is ...
-
The changing autarky pharmaceutical R&D process: causes and consequences of growing R&D collaboration in Japanese firms
This paper analyses the changing R&D process at Japanese pharmaceutical companies, based on a questionnaire survey as well as structured interviews at large Japanese pharmaceutical companies. Japanese pharmaceutical companies have recently engaged in active R&D collaborations with other firms and universities. This paper identifies the factors underlying this trend, finding that all three factors ...
-
The choice of technology intelligence methods in multinationals: towards a contingency approach
The effectiveness of technology management is fundamentally influenced by the quality of a firm's technology intelligence process, i.e. the acquisition and assessment of information on technological trends. Although there is a vast literature on different technology intelligence methods, there is a lack of research on the factors influencing the choice of appropriate technology intelligence ...
-
Knowledge-based industry after market liberalisation: the case of the local pharmaceutical industry in Central and Eastern Europe
Research of the strategic aspects of the generic pharmaceutical industry in Central and Eastern Europe (CEE) suggests that generic pharmaceutical companies have neglected technological innovation capability, market orientation and performance and have underestimated the process of globalisation. This has resulted in deteriorated performance and lost competitiveness. A recommended approach to ...
-
The changing role of technology suppliers in the pharmaceutical industry: the case of drug delivery companies
In this paper, preliminary results of a research project on strategies of drug delivery companies (DDC) are presented to discuss the changing role of technology suppliers in the pharmaceutical industry. Changes in the pharmaceutical industry are presented briefly and related to developments in the drug delivery industry. The early observations are contrasted with existing views from the ...
-
Conditions for the achievement of pharmaceutical innovation for sustainable development: lessons from India
This paper shows the post-TRIPS experience to be contradicting the overstated claim that "the adverse effect of TRIPS Agreement on prices of patented medicines would be adequately compensated by the benefits of technology transfer and domestic R&D". It argues that policymakers cannot continue to formulate their strategic interventions with an understanding that "strong IPRs are ...
-
Managing research collaborations as a portfolio of contracts: a risk reduction strategy by pharmaceutical firms
This research proposes an empirically derived model of the process through which firms facing high R&D risks and costs, leverage their limited R&D resources, by contracting out upstream (laboratory scale) research at low cost for a portfolio of R&D projects to not-for-profit technology institutions. The firms then concentrate their limited R&D resources on downstream (commercial scale) R&D that ...
-
New trends in biotechnology networking
The paper explores two emerging trends in biotechnology networking: the role of strategic partnering activity in the formation of knowledge-based networked oligopolies particularly in the pharmaceutical industry and the extension of partnering activity in biotechnology from advanced industrial to Third World countries. Both trends, it argues, bear further examination by both researchers seeking ...
-
Ownership, technological intensities, and economic performance in South Africa
This paper examines statistical differences and determinants of labour productivity, and export, skill and technological intensities between foreign and local auto parts, electronics, food, pharmaceutical and garment firms in South Africa. Foreign firms enjoyed higher labour productivity, and export, overall technology, process and R&D intensities than local firms in pharmaceuticals, and export, ...
-
Technological regimes and the evolution of networks of innovators. Lessons from biotechnology and pharmaceuticals
In this paper, we analyse the relationships between technological regimes, regimes of local interaction, and the global structure of an industrial network. Given the complexity of the task, we follow a semi-inductivist approach, combining quantitative empirical analyses and simulative exercises. We show that the topological properties of the R&D network in pharmaceuticals are the result of ...
-
Bioprospecting: lessons from benefit-sharing experiences
Biodiversity prospecting, or bioprospecting, is the exploration of biodiversity for commercially valuable genetic and biochemical resources. The Convention on Biological Diversity recognises the sovereignty of nations over their bioresources and their rights to share in the benefits that accrue from commercialised bioproducts. Since the Convention was introduced in 1992, many biodiversity ...
-
The Effects of Excipients on Pharmaceutical Preparation
Excipients are very important for pharmaceutical preparations. It can be said that without excipients, there will be no pharmaceutical preparations, let alone different pharmaceutical dosage forms such as powders, granules, tablets, oral liquids or injections. When the drug and the appropriate excipients are combined into a specific dosage form, the drug would become safer, more stable and more ...
-
The Effects of Excipients on Pharmaceutical Preparations in Drug Design
Excipients are very important for pharmaceutical preparations. It can be said that without excipients, there will be no pharmaceutical preparations, let alone different pharmaceutical dosage forms such as powders, granules, tablets, oral liquids or injections. When the drug and the appropriate excipients are combined into a specific dosage form, the drug would become safer, more stable and more ...
-
Decoding Protein Structure Modeling: Unlocking the Key to Life's Mysteries
Proteins are among the most vital molecules in living organisms, playing crucial roles in cell function, signal transduction, and drug development, to name just a few. However, directly observing and studying the three-dimensional structures of proteins is not an easy task. Fortunately, the development of protein structure modeling technology has provided us with a powerful tool to unravel the ...
-
Q&A with Dr. Cindy Shu, REDI Fellow
After being awarded the MTPConnect REDI Fellowship Grant in August 2020, Postdoctoral Research Fellow from the Kolling Institute and University of Sydney Royal North Shore Hospital, Dr. Cindy Shu is joining Regeneus for a 12-month project focused on readying Progenza™ for Phase II trials in Japan and the U.S. A Medical Research Future Fund initiative, the grant provides financial support ...
-
Recursion Pharmaceuticals Puts Strength on Full Display
The drug developer's latest capital raise, a $150 million private placement, comes during a difficult market environment. The strongest companies can raise money in any environment. Recursion Pharmaceuticals (RXRX) - Get Free Report recently raised $150 million in gross proceeds from a private placement of common stock, including half from a single fund that has never before invested in the ...
By Recursion
-
Indonesia Hospital Expo
Indonesia Hospital Expo in Jakarta is a fast growing regional show with 28,000-30,000 visitors. It is cited by Indonesian healthcare companies and medical distributors as the main Indonesian healthcare show that they attend. Indonesian International Hospital Expo will provide the best opportunity for medical equipment players to introduce their products and innovations besides exchange of ...
-
A European innovation system in pharmaceuticals?
This paper analyses the emergence and development of a European pharmaceutical system. In particular it reviews and assesses the influence of new institutional and regulatory frameworks on the creation of this pan-European pharmaceutical system. The paper then explores the implications of the formation of this process on our conceptualisation of the more specific "systems of innovation" ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you